These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38498996)

  • 1. Casiopeina III-ia: A Copper Compound with Potential Use for Treatment of Infections Caused by Leishmania mexicana.
    Delgado-Domínguez J; Mejía-Camacho L; Torres-Martínez L; Zamora-Chimal J; Cervantes-Sarabia R; Espinoza-Guillen A; Ruiz-Azuara L; Becker I
    Chemotherapy; 2024; 69(3):168-176. PubMed ID: 38498996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
    Soyer TG; Mendonça DVC; Tavares GSV; Lage DP; Dias DS; Ribeiro PAF; Perin L; Ludolf F; Coelho VTS; Ferreira ACG; Neves PHAS; Matos GF; Chávez-Fumagalli MA; Coimbra ES; Pereira GR; Coelho EAF; Antinarelli LMR
    Exp Parasitol; 2019 Apr; 199():30-37. PubMed ID: 30817917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo activity of a palladacycle complex on Leishmania (Leishmania) amazonensis.
    Paladi Cde S; Pimentel IA; Katz S; Cunha RL; Judice WA; Caires AC; Barbiéri CL
    PLoS Negl Trop Dis; 2012; 6(5):e1626. PubMed ID: 22616018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-Quinolinylhydrazone analogues kill Leishmania (Leishmania) amazonensis by inducing apoptosis and mitochondria-dependent pathway cell death.
    Granato JDT; Silva ETD; Lemos ASO; Machado PA; Midlej VDV; Antinarelli LMR; Silva Neto AFD; Souza MVN; Coimbra ES
    Chem Biol Drug Des; 2024 May; 103(5):e14535. PubMed ID: 38772877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semicarbazone derivatives as promising therapeutic alternatives in leishmaniasis.
    Cavalcanti de Queiroz A; Alves MA; Barreiro EJ; Lima LM; Alexandre-Moreira MS
    Exp Parasitol; 2019 Jun; 201():57-66. PubMed ID: 31004571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leishmanicidal activity of the Agaricus blazei Murill in different Leishmania species.
    Valadares DG; Duarte MC; Oliveira JS; Chávez-Fumagalli MA; Martins VT; Costa LE; Leite JP; Santoro MM; Régis WC; Tavares CA; Coelho EA
    Parasitol Int; 2011 Dec; 60(4):357-63. PubMed ID: 21723957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of total phenolic fraction derived from extra virgin olive oil for its antileishmanial activity.
    Koutsoni OS; Karampetsou K; Kyriazis ID; Stathopoulos P; Aligiannis N; Halabalaki M; Skaltsounis LA; Dotsika E
    Phytomedicine; 2018 Aug; 47():143-150. PubMed ID: 30166099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antileishmanial Activity, Cytotoxicity and Mechanism of Action of Clioquinol Against Leishmania infantum and Leishmania amazonensis Species.
    Tavares GSV; Mendonça DVC; Lage DP; Granato JDT; Ottoni FM; Ludolf F; Chávez-Fumagalli MA; Duarte MC; Tavares CAP; Alves RJ; Coimbra ES; Coelho EAF
    Basic Clin Pharmacol Toxicol; 2018 Sep; 123(3):236-246. PubMed ID: 29481714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immucillins Impair Leishmania (L.) infantum chagasi and Leishmania (L.) amazonensis Multiplication In Vitro.
    Freitas EO; Nico D; Guan R; Meyer-Fernandes JR; Clinch K; Evans GB; Tyler PC; Schramm VL; Palatnik-de-Sousa CB
    PLoS One; 2015; 10(4):e0124183. PubMed ID: 25909893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of Chitosan and Its Derivatives against Leishmania major and Leishmania mexicana
    Riezk A; Raynes JG; Yardley V; Murdan S; Croft SL
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31871082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro and In Vivo Antileishmanial Activity of Thioridazine.
    Sifontes-Rodríguez S; Mollineda-Diogo N; Monzote-Fidalgo L; Escalona-Montaño AR; Escario García-Trevijano JA; Aguirre-García MM; Meneses-Marcel A
    Acta Parasitol; 2024 Mar; 69(1):324-331. PubMed ID: 38070122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.
    Tavares GSV; Mendonça DVC; Lage DP; Antinarelli LMR; Soyer TG; Senna AJS; Matos GF; Dias DS; Ribeiro PAF; Batista JPT; Poletto JM; Brandão GC; Chávez-Fumagalli MA; Pereira GR; Coimbra ES; Coelho EAF
    Acta Trop; 2019 Mar; 191():29-37. PubMed ID: 30586571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poloxamer 407 (Pluronic(®) F127)-based polymeric micelles for amphotericin B: In vitro biological activity, toxicity and in vivo therapeutic efficacy against murine tegumentary leishmaniasis.
    Mendonça DV; Lage LM; Lage DP; Chávez-Fumagalli MA; Ludolf F; Roatt BM; Menezes-Souza D; Faraco AA; Castilho RO; Tavares CA; Barichello JM; Duarte MC; Coelho EA
    Exp Parasitol; 2016 Oct; 169():34-42. PubMed ID: 27427166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a thiohydantoin salt derived from l-Arginine on Leishmania amazonensis and infected cells: Insights from biological effects to molecular docking interactions.
    da Silva Bortoleti BT; Camargo PG; Gonçalves MD; Tomiotto-Pellissier F; Silva TF; Concato VM; Detoni MB; Bidóia DL; da Silva Lima CH; Rodrigues CR; Bispo MLF; de Macedo FC; Conchon-Costa I; Miranda-Sapla MM; Wowk PF; Pavanelli WR
    Chem Biol Interact; 2024 Nov; 403():111216. PubMed ID: 39218371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of lapachol on treatment of cutaneous and visceral leishmaniasis.
    Araújo IAC; de Paula RC; Alves CL; Faria KF; Oliveira MM; Mendes GG; Dias EMFA; Ribeiro RR; Oliveira AB; Silva SMD
    Exp Parasitol; 2019 Apr; 199():67-73. PubMed ID: 30797783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4-Aminoquinoline Derivatives as Potential Antileishmanial Agents.
    Antinarelli LM; Dias RM; Souza IO; Lima WP; Gameiro J; da Silva AD; Coimbra ES
    Chem Biol Drug Des; 2015 Oct; 86(4):704-14. PubMed ID: 25682728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of a Binuclear Cyclopalladated Compound Therapy for Cutaneous Leishmaniasis in the Murine Model of Infection with Leishmania amazonensis and Its Inhibitory Effect on Topoisomerase 1B.
    Velásquez AMA; Ribeiro WC; Venn V; Castelli S; Camargo MS; de Assis RP; de Souza RA; Ribeiro AR; Passalacqua TG; da Rosa JA; Baviera AM; Mauro AE; Desideri A; Almeida-Amaral EE; Graminha MAS
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28507113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective effects of Euterpe oleracea (açai) on Leishmania (Leishmania) amazonensis and Leishmania infantum.
    Da Silva BJM; Souza-Monteiro JR; Rogez H; Crespo-López ME; Do Nascimento JLM; Silva EO
    Biomed Pharmacother; 2018 Jan; 97():1613-1621. PubMed ID: 29793323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Paromomycin-Chloroquine Combination Therapy in Experimental Cutaneous Leishmaniasis.
    Wijnant GJ; Van Bocxlaer K; Yardley V; Murdan S; Croft SL
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28607026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Apigenin and Miltefosine Combination Therapy against Experimental Cutaneous Leishmaniasis.
    Emiliano YSS; Almeida-Amaral EE
    J Nat Prod; 2018 Aug; 81(8):1910-1913. PubMed ID: 30095915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.